We are live on
!
Find out more
RG
Redmile Group Portfolio holdings
AUM
$1.51B
1-Year Est. Return
164.17%
This Fund
S&P 500
This Quarter
Est. Return
-10.28%
1 Year Est. Return
+164.17%
3 Year Est. Return
+929.47%
5 Year Est. Return
+823.75%
10 Year Est. Return
+18,826.17%
AUM
$1.32B
AUM Growth
+$99.8M
(+8.2%)
Cap. Flow
+$327M
Cap. Flow
% of AUM
24.74%
Top 10 Holdings %
Top 10 Hldgs %
52.92%
Holding
77
New
22
Increased
20
Reduced
12
Closed
19
Top Buys
| 1 |
MDVN
MEDIVATION, INC.
MDVN
|
+$86.8M |
| 2 |
RAD
Rite Aid Corporation
RAD
|
+$67.2M |
| 3 |
Penumbra
PEN
|
+$63.2M |
| 4 |
SAGE
Sage Therapeutics
SAGE
|
+$52.5M |
| 5 |
Incyte
INCY
|
+$50.3M |
Top Sells
| 1 |
Bausch Health
BHC
|
+$85.4M |
| 2 |
AGN
Allergan plc
AGN
|
+$41.5M |
| 3 |
KYTH
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
|
+$36.3M |
| 4 |
HCA Healthcare
HCA
|
+$35.4M |
| 5 |
AbbVie
ABBV
|
+$34.3M |
Sector Composition
| 1 | Healthcare | 77.44% |
| 2 | Communication Services | 1.09% |
| 3 | Industrials | 1% |
| 4 | Technology | 0.23% |
| 5 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FOLD
1
DELISTED
Amicus Therapeutics
FOLD
| $117M | 8.83% |
8,332,930
+2,035,407
| +32% | +$31.9M |
|
|
CLVS
2
DELISTED
Clovis Oncology, Inc.
CLVS
| $88.1M | 6.67% |
957,634
+198,155
| +26% | +$17.1M |
|
|
ARRY
3
DELISTED
Array Biopharma Inc
ARRY
| $80.9M | 6.13% |
17,750,510
+4,126,890
| +30% | +$24.5M |
|
|
MDVN
4
DELISTED
MEDIVATION, INC.
MDVN
| $74.5M | 5.64% |
+1,752,642
| New | +$86.8M |
|
|
5
Incyte
INCY
$23B
| $67.7M | 5.13% |
613,598
+448,603
| +272% | +$50.3M |
|
6
Teva Pharmaceuticals
TEVA
$37B
| $64.2M | 4.87% |
1,137,559
+170,200
| +18% | +$11M |
|
|
SGEN
7
DELISTED
Seagen Inc. Common Stock
SGEN
| $53.6M | 4.06% |
1,390,173
+860,974
| +163% | +$38.8M |
|
|
ITCI
8
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $53M | 4.01% |
1,322,592
+712,421
| +117% | +$23.2M |
|
|
9
Penumbra
PEN
$12.5B
| $51M | 3.86% |
+1,562,587
| New | +$63.2M |
|
|
RAD
10
DELISTED
Rite Aid Corporation
RAD
| $49M | 3.71% |
+403,570
| New | +$67.2M |
|
|
SAGE
11
DELISTED
Sage Therapeutics
SAGE
| $48.4M | 3.66% |
1,142,864
+852,514
| +294% | +$52.5M |
|
|
WCG
12
DELISTED
Wellcare Health Plans, Inc.
WCG
| $44.3M | 3.36% |
+514,273
| New | +$45.1M |
|
|
CMRX
13
DELISTED
Chimerix, Inc.
CMRX
| $40.8M | 3.09% |
1,067,978
+368,553
| +53% | +$18.2M |
|
14
Centene
CNC
$33.1B
| $40.5M | 3.07% |
+1,494,920
| New | +$50M |
|
15
BioMarin Pharmaceuticals
BMRN
$11.4B
| $38.8M | 2.94% |
368,775
+161,031
| +78% | +$21.5M |
|
|
ZSPH
16
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
| $33.8M | 2.56% |
514,107
+211,119
| +70% | +$12.7M |
|
17
Atara Biotherapeutics
ATRA
$76.3M
| $33M | 2.5% |
41,991
+27,085
| +182% | +$33M |
|
|
PTLA
18
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $32.8M | 2.49% |
769,641
+616,941
| +404% | +$29.8M |
|
|
NDRM
19
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
| $30.2M | 2.29% |
+1,462,699
| New | +$30M |
|
|
NSTG
20
DELISTED
NanoString Technologies, Inc.
NSTG
| $22.2M | 1.68% |
1,385,641
-74,101
| -5% | -$1.16M |
|
21
Celldex Therapeutics
CLDX
$3.01B
| $20.6M | 1.56% |
130,268
+128,084
| +5,865% | +$36.3M |
|
|
DBVT
22
DBV Technologies
DBVT
$911M
| $19M | 1.44% |
+53,282
| New | +$21M |
|
|
DVAX
23
DELISTED
Dynavax Technologies
DVAX
| $17.8M | 1.35% |
+724,348
| New | +$20.5M |
|
24
Insmed
INSM
$23.7B
| $17.6M | 1.33% |
947,966
+80,620
| +9% | +$2.01M |
|
|
MODN
25
DELISTED
MODEL N, INC.
MODN
| $14.4M | 1.09% |
1,443,278
| – | – |
|
Similar funds
ORI
GAI
HCMG
FMI
FCM
PP
AM
BFO